Literature DB >> 1531705

Receptor mediation of 5-HT-induced inflammation and nociception in rats.

K J Sufka1, F M Schomburg, J Giordano.   

Abstract

In light of evidence suggesting the proinflammatory and nociceptive action of peripheral serotonin (5-HT), the present study examined dose-dependent parameters of edema and algesia produced by intraplantar injections of 5-HT and the role of heterogeneous 5-HT receptors in these 5-HT-induced responses. Intraplantar 5-HT (0.05, 0.25, 0.5, or 1.0 mumols) produced paw edema at each 5-HT concentration and produced concentration-dependent increases in the nociceptive response as indexed by lifts of, and licks to the affected paw. Intraplantar pretreatment with the 5-HT1 receptor antagonist methysergide at concentrations greater than or equal to 3 nmol attenuated the 5-HT-induced (25 mumols) inflammatory and nociceptive responses. At concentrations greater than or equal to 300 nmol, both 5-HT2 receptor antagonist ketanserin and 5-HT3 receptor antagonist odansetron pretreatment blocked 5-HT-induced inflammatory and nociceptive responses. These results more completely define peripheral 5-HT-receptor-dependent systems of 5-HT-induced inflammation and nociception in rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531705     DOI: 10.1016/0091-3057(92)90058-n

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

1.  The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

Authors:  Karla P Zeitz; Nicolas Guy; Annika B Malmberg; Sahera Dirajlal; William J Martin; Linda Sun; Douglas W Bonhaus; Cheryl L Stucky; David Julius; Allan I Basbaum
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Genetically expressed transneuronal tracer reveals direct and indirect serotonergic descending control circuits.

Authors:  João Manuel Braz; Allan I Basbaum
Journal:  J Comp Neurol       Date:  2008-04-20       Impact factor: 3.215

3.  Anti-hyperalgesic effects of anti-serotonergic compounds on serotonin- and capsaicin-evoked thermal hyperalgesia in the rat.

Authors:  D R Loyd; P B Chen; K M Hargreaves
Journal:  Neuroscience       Date:  2011-12-20       Impact factor: 3.590

4.  Sensitization of visceral afferents to bradykinin in rat jejunum in vitro.

Authors:  A M Brunsden; D Grundy
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

5.  Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT(7) receptors.

Authors:  Esther Martínez-García; Marcello Leopoldo; Enza Lacivita; José A Terrón
Journal:  Headache       Date:  2011 Nov-Dec       Impact factor: 5.887

6.  Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons.

Authors:  Toshio Ohta; Yuki Ikemi; Matsuka Murakami; Toshiaki Imagawa; Ken-Ichi Otsuguro; Shigeo Ito
Journal:  J Physiol       Date:  2006-08-10       Impact factor: 5.182

Review 7.  Serotonin in pain and analgesia: actions in the periphery.

Authors:  Claudia Sommer
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

Review 8.  Serotonergic neuromodulation of peripheral nociceptors.

Authors:  Dayna R Loyd; Michael A Henry; Kenneth M Hargreaves
Journal:  Semin Cell Dev Biol       Date:  2012-09-19       Impact factor: 7.727

9.  NT79: A novel neurotensin analog with selective behavioral effects.

Authors:  Mona Boules; Yanqi Liang; Siobhan Briody; Tomofumi Miura; Irfan Fauq; Alfredo Oliveros; Mina Wilson; Shaheen Khaniyev; Katrina Williams; Zhimin Li; Yanfei Qi; Michael Katovich; Elliott Richelson
Journal:  Brain Res       Date:  2009-10-27       Impact factor: 3.252

10.  Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol.

Authors:  Valentina Ruggieri; Giovanni Vitale; Luigi Alberto Pini; Maurizio Sandrini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.